Identification of potential biomarkers for oral squamous cell carcinoma through multi-cohort bioinformatic analysis.

Authors

Duanreiliu Kamei, Simran Kaur, Anjali Priya, Akshay Bansal, Aarti Yadav, Ashwini Ray, Yamini Agrawal

Published in

Journal of the Egyptian National Cancer Institute. Volume 38. Issue 1. Aug 11, 2026. Epub Aug 11, 2026.

Abstract

Oral squamous cell carcinoma (OSCC) arises in the context of diverse etiological exposures, such as tobacco, alcohol, areca nut use and viral infections. This etiological heterogeneity drives distinct molecular alterations, contributing to tumor complexity and significant challenges in identifying robust, clinically applicable biomarkers.
To resolve this, we employed an integrative bioinformatics approach, analyzing five gene expression datasets retrieved from the GEO repository, which encompass heterogenous clinical samples with diverse clinical stages of OSCC Differentially expressed genes (DEGs) were identified using stringent thresholds (|LogFC|≥ 1.5 to 3.0; p < 0.05), followed by GO and KEGG pathway enrichment analysis. A protein-protein interaction (PPI) connectome was generated, leading to identification of key hub genes using five topological properties. The biological relevance of hub genes was validated via GEPIA, HPA, immune infiltration analysis, and miRNet.
Screening of datasets provided 1764 DEGs. Enrichment analysis revealed dysregulation in immune response, metabolic processes, remodeling of the extracellular matrix, and inflammatory signaling. Five hub genes, EGFR, FN1, IL6, STAT1, and PTPRC, emerged as central regulators with distinct expression-survival profiles and associations with immune infiltration patterns. Notably, STAT1 and IL6 demonstrated context-dependent behavior, reflecting both tumor-intrinsic and microenvironment-derived expression patterns.
This study highlights five key genes with potential diagnostic, prognostic, and therapeutic relevance in OSCC, emphasizing their consistency across clinically heterogeneous patient cohorts.
These results extend a mechanistic understanding of OSCC pathobiology, thus promising leads towards the development of clinically robust biomarkers.

PMID:
42579075
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.